Mark Bunnage, Adam Gilbert, Lyn Jones & Erik Hett describe some questions about the characteristics of protein targets & small-molecule drugs that may be important to consider in drug-discovery projects & could improve prospects for future clin
2,542 followers
2,542 followers
The biotech industry continues to experience significant attrition of drug candidates during phase 2 PoC clinical studies. Mark Bunnage et al describe some questions that may be important to consider and could improve prospects for future clinical success
6,505 followers
RT @grawoig: Commentary: https://t.co/eoqL1PobB7 "Know your target, know your molecule" by Mark E. Bunnage, Adam M. Gilbert, Lyn H. Jones &…
6,505 followers
RT @grawoig: Commentary: https://t.co/eoqL1PobB7 "Know your target, know your molecule" by Mark E. Bunnage, Adam M. Gilbert, Lyn H. Jones &…